Reply to Bourgeois et al., “Incompletely Reported Important Methodological Details and Inaccurate Description of the Formulation That the Control Arms Received in a Gardasil Vaccine Trial”
Guardado en:
Autores principales: | , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
American Society for Microbiology
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/dd0fa99e33384e788978f8eb4c5876b7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:dd0fa99e33384e788978f8eb4c5876b7 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:dd0fa99e33384e788978f8eb4c5876b72021-11-15T15:31:13ZReply to Bourgeois et al., “Incompletely Reported Important Methodological Details and Inaccurate Description of the Formulation That the Control Arms Received in a Gardasil Vaccine Trial”10.1128/mSphere.01010-202379-5042https://doaj.org/article/dd0fa99e33384e788978f8eb4c5876b72020-12-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mSphere.01010-20https://doaj.org/toc/2379-5042Suzanne M. GarlandMarc StebenAmerican Society for Microbiologyarticleplacebo aluminumsafety HPV vaccineMicrobiologyQR1-502ENmSphere, Vol 5, Iss 6 (2020) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
placebo aluminum safety HPV vaccine Microbiology QR1-502 |
spellingShingle |
placebo aluminum safety HPV vaccine Microbiology QR1-502 Suzanne M. Garland Marc Steben Reply to Bourgeois et al., “Incompletely Reported Important Methodological Details and Inaccurate Description of the Formulation That the Control Arms Received in a Gardasil Vaccine Trial” |
format |
article |
author |
Suzanne M. Garland Marc Steben |
author_facet |
Suzanne M. Garland Marc Steben |
author_sort |
Suzanne M. Garland |
title |
Reply to Bourgeois et al., “Incompletely Reported Important Methodological Details and Inaccurate Description of the Formulation That the Control Arms Received in a Gardasil Vaccine Trial” |
title_short |
Reply to Bourgeois et al., “Incompletely Reported Important Methodological Details and Inaccurate Description of the Formulation That the Control Arms Received in a Gardasil Vaccine Trial” |
title_full |
Reply to Bourgeois et al., “Incompletely Reported Important Methodological Details and Inaccurate Description of the Formulation That the Control Arms Received in a Gardasil Vaccine Trial” |
title_fullStr |
Reply to Bourgeois et al., “Incompletely Reported Important Methodological Details and Inaccurate Description of the Formulation That the Control Arms Received in a Gardasil Vaccine Trial” |
title_full_unstemmed |
Reply to Bourgeois et al., “Incompletely Reported Important Methodological Details and Inaccurate Description of the Formulation That the Control Arms Received in a Gardasil Vaccine Trial” |
title_sort |
reply to bourgeois et al., “incompletely reported important methodological details and inaccurate description of the formulation that the control arms received in a gardasil vaccine trial” |
publisher |
American Society for Microbiology |
publishDate |
2020 |
url |
https://doaj.org/article/dd0fa99e33384e788978f8eb4c5876b7 |
work_keys_str_mv |
AT suzannemgarland replytobourgeoisetalincompletelyreportedimportantmethodologicaldetailsandinaccuratedescriptionoftheformulationthatthecontrolarmsreceivedinagardasilvaccinetrial AT marcsteben replytobourgeoisetalincompletelyreportedimportantmethodologicaldetailsandinaccuratedescriptionoftheformulationthatthecontrolarmsreceivedinagardasilvaccinetrial |
_version_ |
1718427857768677376 |